... shares of the company's stock worth $175,001,000 after acquiring an additional 3,095,804 shares during the period. Ardsley Advisory Partners lifted its holdings in shares of TherapeuticsMD by 4,100.0% during the 4th quarter. Ardsley Advisory ...
https://www.americanbankingnews.com/2018/02/24/zacks-analysts-expect-therapeuticsmd-inc-txmd-will-announce-quarterly-sales-of-4-22-million.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+AmericanBankingNews+%28American+Banking+News%29
No comments:
Post a Comment